Author Question: Clients identified with hyperlipidemia postkidney transplant should be treated with a lipid-lowering ... (Read 40 times)

Garrulous

  • Hero Member
  • *****
  • Posts: 686
Clients identified with hyperlipidemia postkidney transplant should be treated with a lipid-lowering agent and a therapeutic diet to prevent:
 
  1. Hypertension.
   2. Peripheral neuropathy.
   3. Diabetes.
   4. Cardiovascular disease.

Question 2

To reduce the risk of aspiration, patients who are receiving enteral tube feedings should be positioned
 
  a. sitting upright.
  b. lying on their side.
  c. with the head of the bed elevated 30 to 45 degrees.
  d. with the head of the bed elevated 45 to 60 degrees.



Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

4

Rationale: Clients who are identified postkidney transplant to have hyperlipidemia should be treated with a lipid-lowering agent and a therapeutic diet to prevent cardiovascular disease. Hyperlipidemia is reported in about 90 of clients postkidney transplant. Hypertension, which may result from sodium retention caused as an adverse side effect of medications, may also contribute to cardiac risk along with diabetes. Peripheral neuropathy is not caused by hyperlipidemia.

Answer to Question 2

C
Patients who are receiving enteral tube feedings should be positioned with the head of the bed elevated 30 to 45 degrees to help prevent aspiration. They do not need to sit upright. Lying on their side does not reduce the risk of aspiration.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

For a complete list of videos, visit our video library